Skip to main content
. 2019 Jun 4;2019(6):CD012902. doi: 10.1002/14651858.CD012902.pub2

Blum 1989.

Methods Randomized, controlled
Method of randomisation: date of birth
Kind of shunt: ventriculoperitoneal shunts, ventriculoatrial shunts and subduro‐peritoneal shunts
Location: Germany
Follow‐up: 8 weeks
Duration: 2.5 years
Participants Inclusion: children up to 14 years of age operated for hydrocephalus of various aetiologies
Exclusion: hypersensitivity to selected drug, patients who received antibiotic therapy in the period from 7 days before the operation, prophylactic antibiotic in the same period, concurrent infections, immunosuppressive therapy, diabetes and other factors that impair wound healing, prophylaxis inadvertently continued or another antibiotic administered within 10 days of operation. Any of the following diseases: agammaglobulinaemia, agranulocytosis, leukaemia, severe anaemia, lymphoma, thymus aplasia, melanoma, cirrhosis of the liver, burns or uremia
Treatment: 50; control: 50 (66 ventriculoperitoneal shunts, 30 ventriculoatrial shunts and 4 duro‐peritoneal shunts)
Interventions Intravenous prophylactic cefazedone (50 mg/kg) versus placebo
Outcomes Proportion of participants who had shunt infection
7 shunt infections occurred in the first 7 days and the other 3 were reported between the 2nd and 8th week
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk "All patients with an even date of birth were allocated to active treatment group"
Allocation concealment (selection bias) High risk Birth dates can be checked
Blinding of participants and personnel (performance bias) 
 All outcomes High risk "Single blinded"
Blinding of outcome assessment (detection bias) 
 All outcomes High risk "Single blinded"
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No missing outcome data
Selective reporting (reporting bias) Low risk Study protocol is not available but published reports include all expected outcomes including analysis
Other bias Unclear risk The difference in outcome between the treatment group and control group seems substantial but it is not statistically significant. Other biases than the above described could contribute to this effect